{
    "clinical_study": {
        "@rank": "94073", 
        "arm_group": {
            "arm_group_label": "Enhanced meter feature usability", 
            "arm_group_type": "Other", 
            "description": "Home diabetes monitoring by patient using provided blood glucose monitoring system."
        }, 
        "brief_summary": {
            "textblock": "This enhanced meter feature raises awareness among patients by providing additional\n      information regarding their glycemic control in between Healthcare Professional visits. This\n      information may facilitate increased dialogue between patient and Healthcare Professional\n      and can remind patients of the importance of glycemic control.\n\n      This study will evaluate a user's ability to use the enhanced meter feature."
        }, 
        "brief_title": "User Study for Enhanced Meter Feature", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n        IC 1. Age of subject is 18 years or older\n\n        IC 2. Type I or type II diabetes inclusive of the following populations:\n\n          1. Mixed insulin therapies\n\n          2. Basal insulin therapies\n\n          3. Bolus insulin therapies\n\n          4. CSII therapies\n\n          5. MDI therapies\n\n          6. Non-insulin diabetic treatments (oral and injectable)\n\n          7. Life style (exercise and diet) diabetes management IC 3. Able to speak and read\n             English proficiently\n\n        Exclusion criteria EC 1. Pregnant EC 2. Hct <20 or >60 EC 3. Work for BGM competitor\n        company (including, but not limited to Lifescan, Roche, Abbott) EC 4. Homeless EC 5.\n        Incarcerated EC 6. Institutionalized EC 7. Employees or students of the Research Site,\n        including the Principal Investigator, directly involved in the conduct of the protocol.\n\n        EC 8. Has any condition that the Principal Investigator believes may interfere in the\n        subject's participation in the study.\n\n        EC 9. Previous experience using the MyStar Extra BGMS"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01889355", 
            "org_study_id": "AGAFPGM01"
        }, 
        "intervention": {
            "arm_group_label": "Enhanced meter feature usability", 
            "intervention_name": "AgaMatrix Blood Glucose Monitor", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "keyword": [
            "diabetes", 
            "glucose", 
            "glucometer"
        ], 
        "lastchanged_date": "March 26, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Atlanta", 
                    "country": "United States", 
                    "state": "Georgia", 
                    "zip": "30318"
                }, 
                "name": "Atlanta Diabetes Associates"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "User Study for the Evaluation of an Enhanced Meter Feature Using an AgaMatrix BGMS", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Enhanced meter feature usability", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01889355"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "AgaMatrix, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AgaMatrix, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}